Literature DB >> 10744815

Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy.

K C Noshirwani1, R U van Stolk, L A Rybicki, G J Beck.   

Abstract

BACKGROUND: Three-year colonoscopic surveillance after initial polypectomy may not be required for all patients. Those with multiple baseline polyps and large adenomas, implicated as predictors of colon cancer, merit close observation. Conversely, patients with single small adenomas may be subjected to early endoscopic surveillance unnecessarily.
METHODS: From our Adenoma Registry we evaluated patient and adenoma characteristics in 697 patients. All had an adenoma recurrence within 3 years of a positive baseline colonoscopy. Potential risk factors studied were age, gender, number of adenomas, size of largest adenoma and histology. We defined a significant outcome as size of 1 cm or greater, tubulovillous or villous histology, high-grade dysplasia, carcinoma in situ, invasive cancer, or 4 or more adenomas.
RESULTS: Having 3 or more adenomas on initial colonoscopy with at least 1 measuring 1 cm or larger greatly increased the chance of a significant finding on the first surveillance colonoscopy. Conversely, patients with 1 or 2 adenomas all measuring less than 1 cm were at extremely low risk of an important outcome within 3 years.
CONCLUSIONS: Patients with 1 or 2 adenomas all measuring less than 1 cm are an identified low risk group and their first surveillance examination may be delayed beyond the standard 3 years.

Entities:  

Mesh:

Year:  2000        PMID: 10744815     DOI: 10.1016/s0016-5107(00)70444-5

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  54 in total

Review 1.  The diagnostic and therapeutic roles of colonoscopy: a review.

Authors:  E H Huang; J M Marks
Journal:  Surg Endosc       Date:  2001-12       Impact factor: 4.584

2.  Narrow band imaging to detect residual or recurrent neoplastic tissue during surveillance endoscopy.

Authors:  Jason N Rogart; Harry R Aslanian; Uzma D Siddiqui
Journal:  Dig Dis Sci       Date:  2010-06-09       Impact factor: 3.199

3.  Surveillance guidelines after removal of colorectal adenomatous polyps.

Authors:  W S Atkin; B P Saunders
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  The first year follow-up after colorectal adenoma polypectomy is important: a multiple-center study in symptomatic hospital-based individuals in China.

Authors:  Qin-Yan Gao; Hui-Min Chen; Jian-Qiu Sheng; Ping Zheng; Cheng-Gong Yu; Bo Jiang; Jing-Yuan Fang
Journal:  Front Med China       Date:  2010-12-02

5.  Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population.

Authors:  Yinglong Huang; Wei Gong; Bingzhong Su; Fachao Zhi; Side Liu; Yang Bai; Bo Jiang
Journal:  J Gastroenterol       Date:  2010-03-25       Impact factor: 7.527

6.  A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

Authors:  María Elena Martínez; John A Baron; David A Lieberman; Arthur Schatzkin; Elaine Lanza; Sidney J Winawer; Ann G Zauber; Ruiyun Jiang; Dennis J Ahnen; John H Bond; Timothy R Church; Douglas J Robertson; Stephanie A Smith-Warner; Elizabeth T Jacobs; David S Alberts; E Robert Greenberg
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

7.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

8.  Polyp surveillance.

Authors:  W Donald Buie; Anthony R MacLean
Journal:  Clin Colon Rectal Surg       Date:  2008-11

9.  Risk related surveillance following colorectal polypectomy.

Authors:  G Nusko; U Mansmann; Th Kirchner; E G Hahn
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial.

Authors:  John Z Ayanian; Thomas D Sequist; Alan M Zaslavsky; Richard S Johannes
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.